Literature DB >> 23100568

Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy.

Michael L Rekart1, Mark Gilbert, Rafael Meza, Paul H Kim, Michael Chang, Deborah M Money, Robert C Brunham.   

Abstract

BACKGROUND: Many countries have witnessed a disturbing increase in cases of Chlamydia trachomatis infection despite enhanced control programs. Since the goal of Chlamydia control is to prevent reproductive complications such as pelvic inflammatory disease and ectopic pregnancy, an understanding of recent trends in these conditions is needed to fully evaluate the effect of control efforts.
METHODS: We analyzed 2 provincial, comprehensive health services administrative databases (encompassing hospitalizations and all physician-delivered services) for pelvic inflammatory disease and ectopic pregnancy trends from 1992 through 2009 in women of reproductive age in British Columbia, Canada. Trends were compared to provincial Chlamydia surveillance data by time-series analysis, using the cross-correlation function method and Granger causality testing.
RESULTS: Chlamydia cases substantially increased from 1992 through 2009. Inpatient, outpatient, and total diagnoses of pelvic inflammatory disease and ectopic pregnancy declined from 1992 through 2003. After 2003, pelvic inflammatory disease rates continued to fall, while ectopic pregnancy rates significantly increased. The male Chlamydia urethritis rate increased from 39.4 to 173.6 cases/100,000 from 1996 to 2009.
CONCLUSIONS: In the context of increasing Chlamydia infection rates, the reproductive complications of Chlamydia infection in women are declining overall. A recent increase in rates of ectopic pregnancies is cause for concern.

Entities:  

Mesh:

Year:  2012        PMID: 23100568     DOI: 10.1093/infdis/jis644

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Testing-adjusted chlamydia notification trends in New South Wales, Australia, 2000 to 2010.

Authors:  Michelle Cretikos; Darren Mayne; Roderick Reynolds; Paula Spokes; Daniel Madeddu
Journal:  Western Pac Surveill Response J       Date:  2014-08-14

2.  Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents.

Authors:  Yan Zhang; Yuqi Xian; Leiqiong Gao; Hiba Elaasar; Yao Wang; Lamiya Tauhid; Ziyu Hua; Li Shen
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 3.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

4.  Multipart Chaperone-Effector Recognition in the Type III Secretion System of Chlamydia trachomatis.

Authors:  Li Shen; Megan A Macnaughtan; Kyla M Frohlich; Yanguang Cong; Octavia Y Goodwin; Chau-wen Chou; Louis LeCour; Kristen Krup; Miao Luo; David K Worthylake
Journal:  J Biol Chem       Date:  2015-10-05       Impact factor: 5.157

5.  National trends in pelvic inflammatory disease among adolescents in the emergency department.

Authors:  Monika Goyal; Adam Hersh; Xianqun Luan; Russell Localio; Maria Trent; Theoklis Zaoutis
Journal:  J Adolesc Health       Date:  2013-06-03       Impact factor: 5.012

Review 6.  A re-evaluation of the role of B cells in protective immunity to Chlamydia infection.

Authors:  Lin-Xi Li; Stephen J McSorley
Journal:  Immunol Lett       Date:  2015-02-20       Impact factor: 3.685

7.  Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.

Authors:  Karuna P Karunakaran; Hong Yu; Xiaozhou Jiang; Queenie W T Chan; Leonard J Foster; Raymond M Johnson; Robert C Brunham
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

8.  Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection.

Authors:  William M Geisler; Shelly Y Lensing; Christen G Press; Edward W Hook
Journal:  J Infect Dis       Date:  2013-03-07       Impact factor: 5.226

Review 9.  Chlamydia trachomatis control requires a vaccine.

Authors:  Robert C Brunham; Rino Rappuoli
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

10.  Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D.

Authors:  Yanyan Qu; Lauren C Frazer; Catherine M O'Connell; Alice F Tarantal; Charles W Andrews; Shelby L O'Connor; Ali N Russell; Jeanne E Sullivan; Taylor B Poston; Abbe N Vallejo; Toni Darville
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.